Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

  1. van Mackelenbergh, M.T.
  2. Loibl, S.
  3. Untch, M.
  4. Buyse, M.
  5. Geyer, C.E.
  6. Gianni, L.
  7. Schneeweiss, A.
  8. Conte, P.
  9. Piccart, M.
  10. Bonnefoi, H.
  11. Jackisch, C.
  12. Nekljudova, V.
  13. Tang, G.
  14. Valagussa, P.
  15. Neate, C.
  16. Gelber, R.
  17. Poncet, C.
  18. Squifflet, P.
  19. Saad, E.D.
  20. Heinzmann, D.
  21. Denkert, C.
  22. Rastogi, P.
  23. Cortes, J.
  24. Guarneri, V.
  25. de Azambuja, E.
  26. Cameron, D.
  27. Ismael, G.
  28. Wolmark, N.
  29. Cortazar, P.
  30. Mostrar todos los/as autores/as +
Revista:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Año de publicación: 2023

Volumen: 41

Número: 16

Páginas: 2998-3008

Tipo: Artículo

DOI: 10.1200/JCO.22.02241 GOOGLE SCHOLAR